New study tests best way to start lifesaving addiction medication
NCT ID NCT07469501
Summary
This study aims to find the best way to start buprenorphine, a medication for opioid addiction, in people who use fentanyl. It will compare two methods: a slow, low-dose start versus a direct injection. Researchers will track 50 participants for 90 days to see which approach helps people stay in treatment longer, reduces cravings and withdrawal, and lowers fentanyl use.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for OPIOID USE DISORDER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
San Francisco Outpatient Buprenorphine Induction Clinic
San Francisco, California, 94103, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.